T. Rowe Price Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.58M | Buy |
137,926
+5,577
| +4% | +$307K | ﹤0.01% | 1174 |
|
2025
Q1 | $9.36M | Sell |
132,349
-460,044
| -78% | -$32.5M | ﹤0.01% | 1125 |
|
2024
Q4 | $38.9M | Sell |
592,393
-71,162
| -11% | -$4.68M | ﹤0.01% | 821 |
|
2024
Q3 | $46.6M | Sell |
663,555
-319,785
| -33% | -$22.5M | 0.01% | 773 |
|
2024
Q2 | $81M | Sell |
983,340
-118,973
| -11% | -$9.8M | 0.01% | 590 |
|
2024
Q1 | $96.3M | Sell |
1,102,313
-503,670
| -31% | -$44M | 0.01% | 559 |
|
2023
Q4 | $155M | Buy |
1,605,983
+401,152
| +33% | +$38.7M | 0.02% | 459 |
|
2023
Q3 | $107M | Sell |
1,204,831
-86,847
| -7% | -$7.68M | 0.02% | 502 |
|
2023
Q2 | $112M | Sell |
1,291,678
-2,369
| -0.2% | -$205K | 0.02% | 501 |
|
2023
Q1 | $126M | Buy |
1,294,047
+366,211
| +39% | +$35.6M | 0.02% | 471 |
|
2022
Q4 | $96M | Buy |
927,836
+316,129
| +52% | +$32.7M | 0.02% | 503 |
|
2022
Q3 | $51.9M | Buy |
611,707
+86,888
| +17% | +$7.37M | 0.01% | 637 |
|
2022
Q2 | $43.5M | Sell |
524,819
-1,064,526
| -67% | -$88.2M | 0.01% | 920 |
|
2022
Q1 | $123M | Buy |
1,589,345
+370,312
| +30% | +$28.6M | 0.01% | 665 |
|
2021
Q4 | $108M | Buy |
1,219,033
+4,146
| +0.3% | +$366K | 0.01% | 740 |
|
2021
Q3 | $93.9M | Sell |
1,214,887
-445,429
| -27% | -$34.4M | 0.01% | 790 |
|
2021
Q2 | $139M | Sell |
1,660,316
-250,194
| -13% | -$20.9M | 0.01% | 672 |
|
2021
Q1 | $144M | Sell |
1,910,510
-154,072
| -7% | -$11.6M | 0.01% | 656 |
|
2020
Q4 | $181M | Buy |
2,064,582
+109,300
| +6% | +$9.58M | 0.02% | 552 |
|
2020
Q3 | $149M | Buy |
1,955,282
+515,857
| +36% | +$39.2M | 0.02% | 551 |
|
2020
Q2 | $178M | Buy |
1,439,425
+25,517
| +2% | +$3.15M | 0.02% | 497 |
|
2020
Q1 | $119M | Sell |
1,413,908
-702,146
| -33% | -$59.3M | 0.02% | 525 |
|
2019
Q4 | $179M | Sell |
2,116,054
-128,267
| -6% | -$10.8M | 0.02% | 504 |
|
2019
Q3 | $151M | Sell |
2,244,321
-51,883
| -2% | -$3.5M | 0.02% | 507 |
|
2019
Q2 | $197M | Sell |
2,296,204
-185,337
| -7% | -$15.9M | 0.03% | 470 |
|
2019
Q1 | $220M | Buy |
2,481,541
+207,251
| +9% | +$18.4M | 0.03% | 441 |
|
2018
Q4 | $194M | Sell |
2,274,290
-158,692
| -7% | -$13.5M | 0.03% | 443 |
|
2018
Q3 | $236M | Sell |
2,432,982
-88,501
| -4% | -$8.58M | 0.03% | 444 |
|
2018
Q2 | $238M | Buy |
2,521,483
+247,675
| +11% | +$23.3M | 0.04% | 430 |
|
2018
Q1 | $184M | Sell |
2,273,808
-148,606
| -6% | -$12M | 0.03% | 481 |
|
2017
Q4 | $216M | Buy |
2,422,414
+413,363
| +21% | +$36.9M | 0.04% | 444 |
|
2017
Q3 | $187M | Buy |
2,009,051
+368,486
| +22% | +$34.3M | 0.03% | 465 |
|
2017
Q2 | $149M | Buy |
1,640,565
+153,834
| +10% | +$14M | 0.03% | 505 |
|
2017
Q1 | $131M | Buy |
1,486,731
+295,308
| +25% | +$25.9M | 0.02% | 524 |
|
2016
Q4 | $98.7M | Sell |
1,191,423
-1,395,706
| -54% | -$116M | 0.02% | 600 |
|
2016
Q3 | $239M | Sell |
2,587,129
-938,185
| -27% | -$86.8M | 0.05% | 377 |
|
2016
Q2 | $274M | Sell |
3,525,314
-2,693,446
| -43% | -$210M | 0.06% | 327 |
|
2016
Q1 | $513M | Sell |
6,218,760
-1,808,053
| -23% | -$149M | 0.11% | 213 |
|
2015
Q4 | $841M | Buy |
8,026,813
+491,119
| +7% | +$51.4M | 0.18% | 137 |
|
2015
Q3 | $794M | Sell |
7,535,694
-461,769
| -6% | -$48.6M | 0.18% | 135 |
|
2015
Q2 | $1.09B | Sell |
7,997,463
-177,126
| -2% | -$24.2M | 0.23% | 112 |
|
2015
Q1 | $1.02B | Buy |
8,174,589
+6,235,807
| +322% | +$777M | 0.21% | 117 |
|
2014
Q4 | $175M | Sell |
1,938,782
-98,611
| -5% | -$8.91M | 0.04% | 466 |
|
2014
Q3 | $147M | Sell |
2,037,393
-116,132
| -5% | -$8.38M | 0.03% | 500 |
|
2014
Q2 | $134M | Sell |
2,153,525
-146,424
| -6% | -$9.11M | 0.03% | 550 |
|
2014
Q1 | $157M | Sell |
2,299,949
-376,976
| -14% | -$25.7M | 0.04% | 496 |
|
2013
Q4 | $188M | Sell |
2,676,925
-167,305
| -6% | -$11.8M | 0.04% | 445 |
|
2013
Q3 | $205M | Sell |
2,844,230
-97,060
| -3% | -$7.01M | 0.05% | 395 |
|
2013
Q2 | $164M | Buy |
+2,941,290
| New | +$164M | 0.04% | 439 |
|